+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Inhalation Sedatives Global Market Report 2020-30: COVID-19 Growth and Change

  • ID: 5228426
  • Report
  • December 2020
  • Region: Global
  • The Business Research Company

FEATURED COMPANIES

  • AbbVie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Novartis AG
  • Piramal Enterprises Ltd
Inhalation Sedatives Global Market Report 2020-30: COVID-19 Growth and Change provides the strategists, marketers and senior management with the critical information they need to assess the global inhalation sedatives market.



This report focuses on inhalation sedatives market which is experiencing strong growth. The report gives a guide to the inhalation sedatives market which will be shaping and changing our lives over the next ten years and beyond, including the market's response to the challenge of the global pandemic.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Description:

Where is the largest and fastest growing market for the inhalation sedatives? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Inhalation Sedatives market global report answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider inhalation sedatives market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The inhalation sedatives market section of the report gives context. It compares the inhalation sedatives market with other segments of the inhalation sedatives market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, inhalation sedatives indicators comparison.
Scope

Markets Covered:
1) By Product: Sevoflurane; Desflurane; Isoflurane; Nitrous Oxide
2) By Application: Induction; Maintenance
3) By End-User: Hospitals; Ambulatory Surgical Centers; Others

Companies Mentioned: AbbVie Inc.; Baxter International Inc.; Fresenius SE & Co. KgaA; Halocarbon Products Corporation; Hikma Pharmaceuticals PLC.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Novartis AG
  • Piramal Enterprises Ltd
1. Executive Summary

2. Inhalation Sedatives Market Characteristics

3. Inhalation Sedatives Market Size And Growth
3.1. Global Inhalation Sedatives Historic Market, 2015 - 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
3.2. Global Inhalation Sedatives Forecast Market, 2019 - 2023F, 2025F, 2030F, $ Billion
3.2.1. Drivers Of The Market
3.2.2. Restraints On the Market

4. Inhalation Sedatives Market Segmentation
4.1. Global Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Sevoflurane
  • Desflurane
  • Isoflurane
  • Nitrous Oxide
4.2. Global Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Induction
  • Maintenance
4.3. Global Inhalation Sedatives Market, Segmentation By End-User, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospitals
  • Ambulatory Surgical Centers
  • Others
5. Inhalation Sedatives Market Regional And Country Analysis
5.1. Global Inhalation Sedatives Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global Inhalation Sedatives Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

6. Asia-Pacific Inhalation Sedatives Market
6.1. Asia-Pacific Inhalation Sedatives Market Overview
6.2. Asia-Pacific Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6.3. Asia-Pacific Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

7. China Inhalation Sedatives Market
7.1. China Inhalation Sedatives Market Overview
7.2. China Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion
7.3. China Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F,$ Billion

8. India Inhalation Sedatives Market
8.1. India Inhalation Sedatives Market Overview
8.2. India Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
8.3. India Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

9. Japan Inhalation Sedatives Market
9.1. Japan Inhalation Sedatives Market Overview
9.2. Japan Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
9.3. Japan Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

10. Australia Inhalation Sedatives Market
10.1. Australia Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
10.2. Australia Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

11. Indonesia Inhalation Sedatives Market
11.1. Indonesia Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
11.2. Indonesia Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

12. South Korea Inhalation Sedatives Market
12.1. South Korea Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
12.2. South Korea Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

13. Western Europe Inhalation Sedatives Market
13.1. Western Europe Inhalation Sedatives Market Overview
13.2. Western Europe Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
13.3. Western Europe Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

14. UK Inhalation Sedatives Market
14.1. UK Inhalation Sedatives Market Overview
14.2. UK Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
14.3. UK Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

15. Germany Inhalation Sedatives Market
15.1. Germany Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
15.2. Germany Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

16. France Inhalation Sedatives Market
16.4. France Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
16.5. France Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

17. Eastern Europe Inhalation Sedatives Market
17.1. Eastern Europe Inhalation Sedatives Market Overview
17.2. Eastern Europe Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
17.3. Eastern Europe Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

18. Russia Inhalation Sedatives Market
18.1. Russia Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
18.2. Russia Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

19. North America Inhalation Sedatives Market
19.1. North America Inhalation Sedatives Market Overview
19.2. North America Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
19.3. North America Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

20. USA Inhalation Sedatives Market
20.1. USA Inhalation Sedatives Market Overview
20.2. USA Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
20.3. USA Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

21. South America Inhalation Sedatives Market
21.1. South America Inhalation Sedatives Market Overview
21.2. South America Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
21.3. South America Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

22. Brazil Inhalation Sedatives Market
22.1. Brazil Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
22.2. Brazil Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

23. Middle East Inhalation Sedatives Market
23.1. Middle East Inhalation Sedatives Market Overview
23.2. Middle East Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
23.3. Middle East Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

24. Africa Inhalation Sedatives Market
24.1. Africa Inhalation Sedatives Market Overview
24.2. Africa Inhalation Sedatives Market, Segmentation By Product, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
24.3. Africa Inhalation Sedatives Market, Segmentation By Application, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion

25. Inhalation Sedatives Market Competitive Landscape And Company Profiles
25.1. Inhalation Sedatives Market Competitive Landscape
25.2. Inhalation Sedatives Market Company Profiles
25.2.1. AbbVie Inc.
25.2.1.1. Overview
25.2.1.2. Products and Services
25.2.1.3. Strategy
25.2.1.4. Financial Performance
25.2.2. Baxter International Inc.
25.2.2.1. Overview
25.2.2.2. Products and Services
25.2.2.3. Strategy
25.2.2.4. Financial Performance
25.2.3. Fresenius SE amp; Co. KgaA
25.2.3.1. Overview
25.2.3.2. Products and Services
25.2.3.3. Strategy
25.2.3.4. Financial Performance
25.2.4. Halocarbon Products Corporation
25.2.4.1. Overview
25.2.4.2. Products and Services
25.2.4.3. Strategy
25.2.4.4. Financial Performance
25.2.5. Hikma Pharmaceuticals PLC.
25.2.5.1. Overview
25.2.5.2. Products and Services
25.2.5.3. Strategy
25.2.5.4. Financial Performance

26. Key Mergers And Acquisitions In The Inhalation Sedatives Market

27. Inhalation Sedatives Market Trends And Strategies

28. Inhalation Sedatives Market Future Outlook and Potential Analysis

29. Appendix
29.1. Abbreviations
29.2. Currencies
29.3. Research Inquiries
29.4. About the Publisher
29.5. Copyright And Disclaimer
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AbbVie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Novartis AG
  • Piramal Enterprises Ltd
Major players in the inhalation sedatives market are AbbVie Inc., Baxter International Inc., Fresenius SE amp; Co. KgaA, Halocarbon Products Corporation, Hikma Pharmaceuticals PLC., Jiangsu Hengrui Medicine Co, Lunan Pharmaceutical Group Co. Ltd, Novartis AG, Piramal Enterprises Ltd and Troikaa Pharmaceuticals Ltd.

The global inhalation sedatives market is expected to increase from $1.27 billion in 2019 to $1.29 billion in 2020 at a compound annual growth rate (CAGR) of 1.2%. The growth is mainly due to the COVID-19 outbreak. The infected individuals with severe ARDS require sedation most frequently, and inhalation sedatives are being increasingly considered as they are associated with rapid onset of inhalation and effective outcomes. Inhaled sedatives can reduce lung inflammation, shorten the duration of ventilation and potentially improve survival. The market is then expected to stabilize and reach $1.48 billion in 2023 at a CAGR of 4.8%.

The inhalation sedatives market consists of sales of inhalation sedatives by companies who manufacture them. Inhalation sedatives are the drugs used to induce or maintain inhalation sedation, which is a type of conscious sedation where a drug is inhaled to suppress the central nervous system activity so that there is no much stress on the patient during a surgical process or a treatment and responds to the physician commands without protective reflexes. Inhalation sedatives are used in hospitals, ambulatory surgical centers and other care providing centers.

North America was the largest region in the inhalation sedatives market in 2019. Asia-Pacific is expected to be the fastest-growing region in the forecast period.

The production of generic inhalation sedatives is expected to be the new trend in the inhalation sedatives market. Generics are a type of drug that has the same chemical formula, dosage form, dose and effect as that of the patented drug but are produced by the companies when the patent expires. The generic inhalation sedatives production has increased for the last few years. For instance, in January 2019, Novartis’ division Sandoz has launched a liquid for inhalation called desflurane in the United States, a first generic of an inhalation agent suprane that is used for induction and maintenance in adults and paediatrics. Health Canada has given a receipt of a drug identification number to Blue-Zone Technologies Ltd that permits it to launch the generic desflurane drug. Therefore, the production of generic inhalation sedatives is expected to become the new trend in the inhalation sedatives market.

The inhalation sedatives market covered in this report is segmented by product into sevoflurane; desflurane; isoflurane; nitrous oxide. It is also segmented by application into induction; maintenance and by end-user into hospitals; ambulatory surgical centers; others.

Contradictions associated with inhalation sedatives are expected to hinder the market. Inhalation sedatives, although safe most of the time, can rarely result in adverse events. For instance, inhalation sedatives cannot be used in patients who have undergone a recent ear surgery as they build up pressure in the middle ear. Also, in pregnant women, the use of inhalation sedatives is avoided to minimize the risk of possible toxicity. Inhalation sedatives affect the foetus by interfering with folic acid absorption in pregnant ladies causing neurotoxicity. Studies show that prolonged exposure to nitrous oxide may cause reproductive and haematological disorders in the operator. The inhalation sedatives also cannot be used for patients with common cold, nasal blockage, or COPD as they cannot be absorbed by the patient, and therefore do not show the required effect. All these factors are causing a hindrance to the usage of inhalation sedatives and an acceptance of other sedative methods. Therefore, contraindications associated with inhalation sedatives are expected to hinder the market.

The short onset and duration time of inhalation sedative is expected to drive the inhalation sedative market. Rapid onset of inhalation sedative and quick recovery rate makes it applicable for short procedures especially in dental surgeries of paediatrics, and in intensive care units for decreasing the pain and quick recovery. For instance, the most commonly used inhaled sedative is nitrous oxide, which is administered as a mixture of 30-70% of oxygen, takes about 1-2 minutes to act and the duration of action is 5 minutes. The short time required for the onset of action and its short duration makes nitrous oxide the most used inhalation sedative for dental treatment. Therefore, the short onset and duration time of inhalation sedatives is expected to drive the inhalation sedatives market.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • AbbVie Inc.
  • Baxter International Inc.
  • Fresenius SE & Co. KGaA
  • Halocarbon Products Corporation
  • Hikma Pharmaceuticals PLC.
  • Jiangsu Hengrui Medicine Co
  • Lunan Pharmaceutical Group Co. Ltd
  • Novartis AG
  • Piramal Enterprises Ltd
  • Troikaa Pharmaceuticals Ltd
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll